Microfluidics Market Is Ready to Observe Highest Revenue Growth up to US$ 12,927.6 Mn by 2027 | Coherent Market Insights

 

Microfluidics Market

The increasing demand for point-of-care (POC) diagnostics, rising frequency of persistent diseases, shorter turnaround times for analyses, and advancements in device portability are driving the growth of the global Microfluidics Market. Point-of-care testing enables medical personnel to diagnose patients in a hospital, field, ambulance, doctor's office, or at home. Due to their need for small sample volumes and usage of micro-fabricated channels for sample analysis, devices aided by microfluidic technology are being used for point-of-care testing. POC testing equipment is already widely utilised in the blood, HIV, glucose, and haemoglobin testing industries. Future POC testing devices might have a strong emphasis on cancer and antibiotic treatments.

Due to the large number of people affected by these diseases in both developed and developing countries, POC testing devices based on microfluidic technology have enormous promise. The clinical diagnostics sector is anticipated to increase at a significant rate during the projected period of time and is estimated to have the largest global Microfluidics Market share. Clinical diagnostics is a significant area of use for microfluidics. A variety of biochemical analysis procedures can be used to identify diseases, such as toxicity, and they can also be detected by observing symptoms. Before visible damage to microscopic cells or other types of symptoms, changes in the patients' blood can indicate organ dysfunction or damage.

The Global Microfluidics Market Is Estimated To Account For US$ 3,800.4 Mn In Terms Of Value In 2018 And Is Expected To Reach US$ 12,927.6 Mn By The End Of 2027.

With the use of plastic microfluidic chips that are fully integrated, have the ability to identify or sample a patient, and that too with no or minimal invasion, there has been an increase in the demand for the development of an affordable and simple-to-handle biochip for clinical diagnostics. Therefore, it is anticipated that the development of clinical diagnostics would contribute to the growth of the worldwide Microfluidics Market.

The greatest Microfluidics Market share currently belongs to the North American area, and it is anticipated that this dominance will last during the projected period. This is attributed to a number of causes, including improved reimbursement regulations, an established healthcare system, and a higher percentage of advanced therapy adoption by the populace. With regard to significant budget cuts for research and development, microfluidics is expanding at an explosive rate, particularly in the U.S. Microfluidic techniques are primarily used in point-of-care and molecular diagnostics, which have a significant market share in the United States. As a result, the United States controls a large portion of the market in North America.

Top Manufacturers are- Agilent Technologies, PerkinElmer Inc., Thermo Fisher Scientific Inc., Qiagen NV, Bio-Rad Laboratories, Inc., Fluidigm Corporation, Abbott Laboratories, and F. Hoffmann-La Roche Ltd.

Read the Press Release of Microfluidics Market

Comments

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

Ginseng Market Outlook, Analysis and forecast up to 2028

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19